Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OraCoat is a commercial-stage oral healthcare brand focused on consumer and dental-professional products for dry mouth, bad breath, and mouth sores. The brand is built around patented oral-adhering disc technology that slowly releases ingredients in the mouth, including during sleep. Its flagship product is XyliMelts for dry mouth, and the portfolio also includes products such as CankerMelts, FreshMelts, and XyliGel. OraCoat operates as a division/brand associated with Orahealth and is now part of Quest Products following the merger/acquisition of OraHealth. The business is healthcare-related, but it is not a drug-development biotech company with a clinical therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OraCoat.